Pharmaxis Ltd

Press Releases

2004-December-23	US FDA Grants Approval for Aridol TM Phase III Trial (in PDF)
2004-December-14	Successful Share Purchase Plan Lifts Total Proceeds from Recent Capital Raisings to $19.7 Million (in PDF)
2004-November-26	Pharmaxis Secures US Patent for Multiple Sclerosis Treatment (in PDF)
2004-November-22	Pharmaxis Files Aridol IND in the USA (in PDF)
2004-November-12	Pharmaxis Establishes Level One American Depositary Receipt (ADR) Program (in PDF)
2004-October-26	Pharmaxis Aridol Asthma Trial Successful (in PDF)
2004-October-1	AridolTM Update (in PDF)
2004-September-27	Pharmaxis Announces Positive Results from Phase II Trial of BronchitolTM (in PDF)
2004-August-12	AridolTM Selected for Major Independent UK Clinical Study by General Practitioners (in PDF)
2004-July-30	Pharmaxis Successfully Completes Enrolment for its 600-Patient Phase III Trial of AridolTM in Asthma (in PDF)
2004-July-16	Pharmaxis Successfully Completes Patient Enrolment for its Phase II Trial of BronchitolTM in the Lung Disease Bronchiectasis (in PDF)
2017	2017 Press Releases
2016	2016 Press Releases
2015	2015 Press Releases
2014	2014 Press Releases
2013	2013 Press Releases
2012	2012 Press Releases
2011	2011 Press Releases
2010	2010 Press Releases
2009	2009 Press Releases
2008	2008 Press Releases
2007	2007 Press Releases
2006	2006 Press Releases
2005	2005 Press Releases